Hsbc Holdings PLC Adma Biologics, Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q3 2024
A detailed history of Hsbc Holdings PLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 21,550 shares of ADMA stock, worth $435,310. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,550
Previous 45,328
52.46%
Holding current value
$435,310
Previous $506,000
15.02%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ADMA
# of Institutions
317Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$377 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$366 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$263 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$255 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$174 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.97B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...